Latest / Stock Movers / Hims & Hers Gains, Abbott Slides, Allbirds Sinks
Transcript
- 0:02Speaker 1: Bloomberg Audio Studios, podcasts, radio news, The Stock Movers Report,
- 0:10Speaker 1: your roundup of companies making moves in the stock market.
- 0:13Speaker 1: Harnessing the power of Bloomberg data, let's take a look
- 0:17Speaker 1: at some of the stocks on the move today. We
- 0:18Speaker 1: can do that with Bloomberg News. Is Carmen Reinike, she's
- 0:21Speaker 1: in studio, Carmen, what do you got for us? Yeah?
- 0:22Speaker 2: So the first one I'm looking at this morning is
- 0:24Speaker 2: Hymns and Hers. So this is ticker hims SO stocks
- 0:28Speaker 2: a little bit off of its highs of the day
- 0:30Speaker 2: so far, but up about five percent, on track to
- 0:34Speaker 2: extend a rally from yesterday into two days. So this
- 0:37Speaker 2: is after RFK Junior how Secretary said the FDA is
- 0:41Speaker 2: seeking to move or remove excuse me, twelve peptides from
- 0:45Speaker 2: Category two restrictions. This could be really good for Hymns
- 0:48Speaker 2: and Hers. So they have signaled that they would like
- 0:51Speaker 2: to sell peptides once these regulations are loosened. So could
- 0:56Speaker 2: be a good one in this story, not about GLP one.
- 0:59Speaker 2: I know, well a different kind of injection. But you know,
- 1:02Speaker 2: my social media feed is just flooded with the you know,
- 1:05Speaker 2: the Hymns and Hers.
- 1:06Speaker 1: You must have on something once. Yeah, and now the
- 1:09Speaker 1: pain you, as someone who's although obvious candidate.
- 1:12Speaker 2: Do you think that the active ingredient in some JLP
- 1:15Speaker 2: ones is a peptide? Okay, there is a link there,
- 1:19Speaker 2: Thank you for making that. But you're right, a different
- 1:22Speaker 2: a different kind of thing. So that's hims and hers.
- 1:24Speaker 2: The next one I'm looking at right now is Abbot Labs.
- 1:27Speaker 2: So this is ABT. Shares are down four percent right now,
- 1:30Speaker 2: so this is a medical devices firm. It cut its
- 1:33Speaker 2: adjusted earnings per share guidance for the full year. This
- 1:37Speaker 2: was adjusting for its acquisition of Exact Sciences, which is
- 1:40Speaker 2: a cancer screening company. This the so Abbot has bought
- 1:45Speaker 2: this company. It's supposed to help its diagnostics business, which
- 1:48Speaker 2: has been suffering since COVID nineteen. You know, we're just
- 1:52Speaker 2: not testing as much anymore.
- 1:53Speaker 1: This was.
- 1:55Speaker 2: Not beneficial for Abbot. So the company also gave a
- 1:58Speaker 2: profit guidance for the second quarter that fell short of expectations.
- 2:01Speaker 2: So seeing a little bit of red on the screen
- 2:03Speaker 2: today and a pretty big decline for the stock this year.
- 2:06Speaker 1: And last one is actually a big mover from earlier
- 2:09Speaker 1: this week as well.
- 2:10Speaker 2: Yeah, so looking at all birds. This is ticker b
- 2:14Speaker 2: I r D. So yesterday, obviously we saw this huge
- 2:17Speaker 2: run up in the shares after it said it was
- 2:19Speaker 2: pivoting to be an AI company. Obviously UNI formerly a
- 2:22Speaker 2: shoe company. And today the stock is lower, it's down
- 2:26Speaker 2: about twenty percent. I mean still, if you look at
- 2:30Speaker 2: the chart, it's just it's just looking it's looking pretty crazy.
- 2:32Speaker 2: But big decline there, although after you know, a six
- 2:36Speaker 2: hundred percent of to day.
- 2:37Speaker 1: Yeah, the Stock Mover's Report from Bloomberg Radio. Check back
- 2:42Speaker 1: with us throughout the day for the latest roundup of
- 2:44Speaker 1: companies making news on Wall Street and for the latest
- 2:48Speaker 1: market moving headlines. Listen to Bloomberg Radio Live, catch us
- 2:52Speaker 1: on YouTube, Bloomberg dot com, and on Applecarplay and Android
- 2:56Speaker 1: Auto with the Bloomberg Business app.